Actavis Changing Name to Allergan
Actavis PLC raised its profit guidance for 2015, while acquisitions again helped drive revenue growth in the fourth quarter, as the company awaits the close of its deal to buy Botox maker Allergan Inc.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Allergy | Botox | Health | Mergers and Aquisitions | Pharmaceuticals | Profits and Losses